Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Ebiomedicine|April 19, 2021
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patientsEmanuela Balestrieri, Antonella Minutolo, Vita Petrone, et al.
The New Microbiologica|May 29, 2018
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessmentMarco Borderi, Gioacchino Angarano, Andrea Antinori, et al.
Life (Basel, Switzerland)|February 25, 2022
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma ProductionAlessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, et al.
Biomolecules|July 27, 2022
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing ObservationsGaetana Costanza, Pierpaolo Paba, Marco Ciotti, et al.
JMIR Public Health and Surveillance|July 11, 2020
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based SurveyFulvio Adorni, Federica Prinelli, Fabrizio Bianchi, et al.
Journal of Global Antimicrobial Resistance|July 6, 2022
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practiceDaniele Armenia, Federica Forbici, Ada Bertoli, et al.
Frontiers in Immunology|February 3, 2022
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical ImplicationsMarco Iannetta, Doriana Landi, Gaia Cola, et al.
Microbes and Infection|February 2, 2025
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWHVita Petrone, Rossana Scutari, Vincenzo Malagnino, et al.
Journal of Clinical Microbiology|July 14, 2017
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 StrainsLavinia Fabeni, Giulia Berno, Joseph Fokam, et al.
Plos One|January 24, 2013
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencingValentina Svicher, Valeria Cento, Gabriella Rozera, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Ebiomedicine|April 19, 2021
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patientsEmanuela Balestrieri, Antonella Minutolo, Vita Petrone, et al.
The New Microbiologica|May 29, 2018
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessmentMarco Borderi, Gioacchino Angarano, Andrea Antinori, et al.
Life (Basel, Switzerland)|February 25, 2022
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma ProductionAlessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, et al.
Biomolecules|July 27, 2022
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing ObservationsGaetana Costanza, Pierpaolo Paba, Marco Ciotti, et al.
JMIR Public Health and Surveillance|July 11, 2020
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based SurveyFulvio Adorni, Federica Prinelli, Fabrizio Bianchi, et al.
Journal of Global Antimicrobial Resistance|July 6, 2022
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practiceDaniele Armenia, Federica Forbici, Ada Bertoli, et al.
Frontiers in Immunology|February 3, 2022
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical ImplicationsMarco Iannetta, Doriana Landi, Gaia Cola, et al.
Microbes and Infection|February 2, 2025
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWHVita Petrone, Rossana Scutari, Vincenzo Malagnino, et al.
Journal of Clinical Microbiology|July 14, 2017
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 StrainsLavinia Fabeni, Giulia Berno, Joseph Fokam, et al.
Plos One|January 24, 2013
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencingValentina Svicher, Valeria Cento, Gabriella Rozera, et al.
Pageof 31